Good Morning, Traders!…👋

U.S. stock futures showed modest movement early Thursday as investors weighed inflation concerns and awaited another key economic report. Benchmark Treasury yields pulled back slightly after Wednesday’s surge but remained above 4.6%.

Markets will be closely watching the latest wholesale inflation data, following a hotter-than-expected consumer price index (CPI) reading that showed inflation accelerated to 3% in January, rattling stocks on Wednesday.

Meanwhile, the White House announced that President Trump is set to outline reciprocal tariffs on countries that impose levies on U.S. exports. Additionally, Trump stated that he and Russian President Vladimir Putin have agreed to initiate peace talks over the Ukraine conflict, with potential concessions to Russia.

On the earnings front, major companies reporting today include Airbnb, Applied Materials, Coinbase, DraftKings, Deere, and PG&E.

Happening Today

✓ 08:30 AM ET – Initial Jobless Claims

✓ 08:30 AM ET – PPI (MoM) (Jan)

✓ 01:00 PM ET – 30-Year Bond Auction

PREMARKET SNAPSHOT 📈

As of February 13, 2025, U.S. stock futures are mixed, with the S&P 500 and Dow Jones Industrial Average showing slight declines, while the Nasdaq Composite indicates a modest gain. Investors are awaiting the release of the January producer price index, which could provide further insights into inflation trends.

SECTOR SNAPSHOT✨

Yesterday markets faced a sharp sell-off, with most sectors deep in the red. Energy led the declines, followed by Industrials, Consumer Discretionary, and Financials, all posting significant losses. Materials and Real Estate also struggled, while Information Technology and Health Care saw moderate declines. Consumer Staples managed to rise, along with a slight uptick in Communication Services, while Utilities edged lower.

PreMarket Unusual Volume Stocks

📈 Phoenix Motor Inc. (PEV): The company has experienced a significant surge in pre-market volume, trading 69.53 million shares compared to its average volume of 1.13 million. The pre-market price is $0.6550, reflecting an increase of approximately 159.82%.

📈 ProPhase Labs, Inc. (PRPH): PRPH has seen a pre-market volume of 37.19 million shares, substantially higher than its average volume of 0.61 million. The stock is trading at $0.4666 in the pre-market, up by 66.35%.

📈 Tivic Health Systems, Inc. (TIVC): TIVC's pre-market activity includes 19.06 million shares traded, a notable increase from its average volume of 10.67 million. The pre-market price stands at $0.8947, marking a 27.81% rise.

📈 MGO Global Inc. (MGOL): MGOL has a pre-market volume of 18.09 million shares, compared to its average of 16.69 million. The stock is priced at $0.6344 in pre-market trading, up by 39.03%.

📈 Cyngn Inc. (CYN): CYN's pre-market volume has reached 17.3 million shares, significantly above its average of 22.04 million. The pre-market price is $0.1282, reflecting a decrease of 14.53%.

Premarket Picks

Phoenix Motor Inc. (PEV) saw a significant pre-market surge of 133.04%, with its price reaching $0.58. This increase followed the company’s announcement of a 1,557% year-over-year revenue growth, reaching $4.77M for the Third Quarter of 2024.

Tivic Health Systems, Inc. (TIVC) experienced a pre-market surge of 42.20%, bringing its price to $0.99. The surge came after the company revealed it had acquired worldwide exclusive license rights to the late-stage Toll-like Receptor 5 agonist Entolimod from Statera Biopharma, aimed at treating acute radiation syndrome.

MGO Global, Inc. (MGOL) gained 36.58% in pre-market trading, pushing its price to $0.62. The increase was driven by the company issuing a reminder about an upcoming special meeting for stockholders to vote on the business combination agreement with Heidmar.

AppLovin Corporation (APP) saw a pre-market surge of 29.71%, with its price climbing to $493.30. This surge was prompted by the company’s announcement of its Fourth Quarter and Full Year 2024 financial results.

Below is a complete list of hot stocks in pre-market today:

Top Upgrades:

1. Gilead Sciences, Inc. (GILD)

Analyst Firm: DZ Bank
Upgraded: Hold to Buy
Price Target: $108
Yesterday's Close: $103.31

DZ Bank raised its rating on Gilead to "Buy" from "Hold" with a target price of $108. Analysts have set a stock price target range for Gilead Sciences, Inc. with a high of $125.00, a low of $80.00, and a median target of $100.00. The average stock price target stands at $104.04. Gilead is a biopharmaceutical company that focuses on discovering, developing, and commercializing medicines to address unmet medical needs across the United States, Europe, and globally.

2. DuPont de Nemours, Inc. (DD)

Analyst Firm: Barclays
Upgraded: Underweight to Equal-Weight
Price Target: $89
Yesterday's Close: $81.76

Barclays analyst Michael Leithead moved DuPont's rating to "Equal-Weight" from "Underweight," increasing the price target to $89 from $85. DuPont’s stock price target has been set with a high of $116.00, a low of $85.00, and a median of $100.00, with an average target of $98.94. DuPont provides technology-driven materials and solutions across multiple regions, including the U.S., Canada, Asia Pacific, Latin America, Europe, the Middle East, and Africa.

3. HubSpot, Inc. (HUBS)

Analyst Firm: KeyBanc
Upgraded: Sector Weight to Overweight
Price Target: $920
Yesterday's Close: $785.50

KeyBanc upgraded HubSpot to "Overweight" from "Sector Weight," setting a price target of $920. For HubSpot, analysts have set a stock price target with a high of $900.00, a low of $640.00, and a median of $779.00, with the average price target at $784.75. HubSpot offers a cloud-based customer relationship management (CRM) platform to businesses in the Americas, Europe, and the Asia Pacific.

Happy investing,

Maeve Grace
Editor In Chief
Premium Stock Alerts

Important: This newsletter does not provide investment advice. The stocks mentioned should not be taken as recommendations. Your investments are solely your decisions.

Disclosure: I hold no positions in any companies mentioned, either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article.